Gapping up
In reaction to earnings/guidance:
- CNM +8.1%, PLAB +6.4%, FLNC +5.9%, CSV +5% (releases FY24 financial goals)
Other news:
- MRTX +9.6% (receives FDA accelerated approval of KRAZATI)
- MRNA +7.8% (Moderna and Merck (MRK) announce investigational cancer vaccine mRNA-4157/V940 has met primary efficacy endpoint)
- NFE +6.2% (provides update to dividend policy plan to return significant capital to shareholders)
- NRIX +4.9% (presents positive results from Novel BTK Degrader)
- KOPN +3.6% (joint tech solution with OPTAC-X and RealWear)
- NYMT +3.1% (names new President)
- PGEN +3.1% (Phase 1 Dose Escalation Data for Autologous PRGN-3006 UltraCAR-T)
- MASI +3% (hosts Investor Day to detail next phase of its growth trajectory at 7:30 am PT (10:30 am ET))
- EVGO +2.6% (EVgo Inc. and Lyft (LYFT) launch new partnership to accelerate rideshare electrification nationwide)
- BA +2.2% (United (UAL) finalized its order to purchase 100 firm Boeing 787 aircraft scheduled to be delivered starting with eight aircraft in 2024)
- HUT +2% (replaces CFO)
- NYT +1.5% (CFO to retire next year)
- SSRM +1.3% (positive exploration results)
- TNDM +1.1% (to acquire Insulin Patch Pump Developer AMF Medical)
- DEN +1% (announce agreement for CO2 sequestration site with Weyerhaeuser)
Analyst comments:
- PHR +2.5% (upgraded to Buy from Neutral at Citigroup)
- ANGI +1.9% (initiated with a Buy at Citigroup)
- TTD +1.5% (initiated with a Buy at Citigroup)
- EQIX +1.4% (upgraded to Outperform from Market Perform at Cowen)
- W +1.3% (initiated with a Buy at Citigroup)
- ETSY +0.9% (initiated with a Buy at Citigroup)